Portfolio company
TYBR Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
GeniPhys
This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.
Miach Orthopaedics
This company develops bio-engineered surgical implants to facilitate natural healing of torn anterior cruciate ligaments for patients with knee injuries.
Rejoni
This company develops hydrogel systems to prevent intrauterine adhesions and improve healing in women undergoing gynaecological surgery.
Tissium
Tissium develops light-activated programmable polymers for sutureless tissue reconstruction and nerve repair, providing these medical devices to surgeons and hospitals.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Silk Biomaterials
This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.
